comprehensive -WSS

comprehensive

author：knowledge 2025-09-30 16:28:38 - browse：8972

John Crowley pictured with his daughter Megan Crowley — health policy news from STAT — John Crowley pictured with his daughter Megan. Crowley family

WASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday.

Crowley came to biotech when his children were diagnosed with a rare genetic neuromuscular disease. He started working at Bristol Myers Squibb, and started Novazyme, which was eventually successful in creating an enzyme replacement therapy for Pompe disease. He later started and worked for several different biotech companies, most recently with Amicus Therapeutics, which had a drug approved to treat the disease in September.

The trade association’s board chair, Ted Love, served on the board of the company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Fight over Supreme Court dialysis ruling puts kidney patients at risk

entertainment

WSS

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Top private equity targets in 2023: cardiology, clinical trials, lasers

Cano Health’s bankruptcy is a warning for Medicare Advantage

CMS got Medicare Advantage quality rating wrong, judge rules

Adopting new red light myopia treatments may be short

Stopping antidepressants leads to symptoms for 1 in 6 patients

hotspot

comprehensive

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Texas Medical Board asked to define abortion emergency exception

New air purifier tech could be key to improving indoor air quality

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Malaria cases in Florida and Texas: Here’s what you need to know

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Finland to offer bird flu vaccine to select groups of people, a possible global first

BioMarin wins approval for gene therapy to treat hemophilia A

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

leisure time

Global cancer cases to surge 77% by 2050, WHO report says

Illumina board agrees to spin off Grail, as divestment plans proceed

Problems with a popular proposal to regulate AI in health care

Problems with a popular proposal to regulate AI in health care

AstraZeneca stays mum on Medicare drug pricing negotiations

Illumina board agrees to spin off Grail, as divestment plans proceed

focus

hotspot

entertainment

leisure time